The companies also said they would terminate an agreement to codevelop and market the drug.

WSJ: Medivation, Pfizer Alzheimer's Drug Fails to Meet Study Goals

In a statement, the company said it "has demanded that Wachovia and Wells Fargo terminate and not proceed with any proposed transaction, " citing tortuous interference with an exclusivity agreement.

FORBES: Magazine Article